Evidence map›Paper›PMID 33750461›Full record

ArticleJournal of cheminformatics2021

Diversity oriented Deep Reinforcement Learning for targeted molecule generation.

Tiago Pereira, Maryam Abbasi, Bernardete Ribeiro, Joel P Arrais

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Selector: A General Python Library for Diverse Subset Selection.Journal of chemical information and modeling · 2026
    Article
  5. Review
  6. Selector: A General Python Library for Diverse Subset Selection.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tiago PereiraDepartment of Informatics Engineering, Centre for Informatics and Systems of the University of Coimbra, University of Coimbra, Pinhal de Marrocos, Coimbra, Portugal.
Maryam AbbasiDepartment of Informatics Engineering, Centre for Informatics and Systems of the University of Coimbra, University of Coimbra, Pinhal de Marrocos, Coimbra, Portugal. maryam@dei.uc.pt.ORCID http://orcid.org/0000-0002-9011-0734
Bernardete RibeiroDepartment of Informatics Engineering, Centre for Informatics and Systems of the University of Coimbra, University of Coimbra, Pinhal de Marrocos, Coimbra, Portugal.
Joel P ArraisDepartment of Informatics Engineering, Centre for Informatics and Systems of the University of Coimbra, University of Coimbra, Pinhal de Marrocos, Coimbra, Portugal.

Funding

Fundação para a Ciência e a Tecnologia CENTRO-01-0145-FEDER-029266
6 · The paper itself

Abstract

In this work, we explore the potential of deep learning to streamline the process of identifying new potential drugs through the computational generation of molecules with interesting biological properties. Two deep neural networks compose our targeted generation framework: the Generator, which is trained to learn the building rules of valid molecules employing SMILES strings notation, and the Predictor which evaluates the newly generated compounds by predicting their affinity for the desired target. Then, the Generator is optimized through Reinforcement Learning to produce molecules with bespoken properties. The innovation of this approach is the exploratory strategy applied during the reinforcement training process that seeks to add novelty to the generated compounds. This training strategy employs two Generators interchangeably to sample new SMILES: the initially trained model that will remain fixed and a copy of the previous one that will be updated during the training to uncover the most promising molecules. The evolution of the reward assigned by the Predictor determines how often each one is employed to select the next token of the molecule. This strategy establishes a compromise between the need to acquire more information about the chemical space and the need to sample new molecules, with the experience gained so far. To demonstrate the effectiveness of the method, the Generator is trained to design molecules with an optimized coefficient of partition and also high inhibitory power against the Adenosine [Formula: see text] and [Formula: see text] opioid receptors. The results reveal that the model can effectively adjust the newly generated molecules towards the wanted direction. More importantly, it was possible to find promising sets of unique and diverse molecules, which was the main purpose of the newly implemented strategy.

Indexed as

Drug DesignReinforcement LearningRNNSMILES

Identifiers

PMID33750461
PMCPMC7944916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.